Cushman & Wakefield's healthcare capital markets update for the first half of 2024 is focusing heavily on medical outpatient buildings. The short take: volume and pricing have remained muted, but there was continued resiliency in the category.

Medical outpatient buildings, not to be confused with medical office buildings — both being called MOBs, though this report is about the first type — have become important to the overall healthcare industry. Evolving demographics, changing reimbursement policies, and technology make the decentralization of care delivery desirable and necessary.

There had been a sharp increase in the volume and pricing of medical outpatient buildings between 2020 and 2022, but that has fallen due to inflation, rising interest rates, and a lack of liquidity as many sources wait for someone else to take the risk of the plunge. And yet, the asset class has remained "resilient," according to the CRE firm.